BRIEF-Valeant Pharmaceuticals provides update on regulatory matters

Tue May 31, 2016 6:26pm EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

May 31 (Reuters) - Valeant Pharmaceuticals International Inc :

* On issuance of MCTOS,alternative information guidelines,confirms co has fulfilled intentions on compliance with alternative info guidelines

* Autorité des marchés financiers issued a customary management cease trade order on May 17, 2016 relating to trading in securities of co by co's CEO and CFO

* Valeant Pharmaceuticals to hold conference call on June 7, 2016

* There have been no material changes to information relating to company's delay in making Canadian required filings Source text for Eikon: Further company coverage: